A Single-Center, Double-Blind (DB) Study of MEM 3454 on P50 Sensory Gating and Mismatch Negativity in Schizophrenia Patients

NCT00725855 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MEM 3454
DRUG: MEM 3454
DRUG: MEM 3454
DRUG: MEM 3454
DRUG: Placebo for MEM 3454

Sponsor

Memory Pharmaceuticals

Collaborators

[object Object]